Cost–Utility Analysis of Transcatheter Aortic Valve Implantation versus Surgery in High-Risk Severe Aortic Stenosis Patients in Thailand

References

• Carabello BA, Paulus WJ. Aortic stenosis. Lancet. 2009;373(9667):956–966. doi:10.1016/S0140-6736(09)60211-7
   PubMed Web of Science ®Google Scholar
• Osnabrugge RL, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62(11):1002–1012. doi:10.1016/j.jacc.2013.05.015
   PubMed Web of Science ®Google Scholar
• Kang DH, Park SJ, Lee SA, et al. Early surgery or conservative care for asymptomatic aortic stenosis. N Engl J Med. 2020;382(2):111–119. doi:10.1056/NEJMoa1912846
   PubMed Web of Science ®Google Scholar
• Yokoyama Y, Takagi H, Kuno T. Early surgery versus conservative management of asymptomatic severe aortic stenosis: a meta-analysis. J Thorac Cardiovasc Surg. 2020;163:1778–1785.e5.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Lloyd G. Mortality whilst waiting for intervention in symptomatic severe aortic stenosis. Eur Heart J. 2020;6(1):89–90.
   Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–1607. doi:10.1056/NEJMoa1008232
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–1620. doi:10.1056/NEJMoa1514616
   PubMed Web of Science ®Google Scholar
• Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–2198. doi:10.1056/NEJMoa1103510
   PubMed Web of Science ®Google Scholar
• Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2021;143(5):e72–e227. doi:10.1161/CIR.0000000000000923
   PubMed Web of Science ®Google Scholar
• Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;43:ehab395.
   Web of Science ®Google Scholar
• Mohara A, Youngkong S, Velasco RP, et al. Using health technology assessment for informing coverage decisions in Thailand. J Comp Eff Res. 2012;1(2):137–146. doi:10.2217/cer.12.10
   PubMed Web of Science ®Google Scholar
• Teerawattananon Y, Eames J, Dabak S. Designing the health benefit package: the essential component of a successful universal health coverage program; 2018. Available from: https://www.hitap.net/wp-content/uploads/2018/11/PB-India-Designing-HBP-for-web.pdf. Accessed June 30, 2022.
   Google Scholar
• Chinnacom D, Doungthipsirikul S, Poonchai A, Patchanee K, Prakongsai P. Health technology assessment and the development of benefit packages under the Universal Coverage Scheme. J Health Serv Res. 2019;13(1):34–46.
   Google Scholar
• Kumar A, Sato K, Narayanswami J, et al. Current Society of thoracic surgeons model reclassifies mortality risk in patients undergoing transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2018;11(9):e006664. doi:10.1161/CIRCINTERVENTIONS.118.006664
   PubMed Web of Science ®Google Scholar
• Wongpraparut N, Sakiyalak P, Jakrapanichakul D, et al. Ten Years’ Experience of Transcatheter Aortic Valve Replacement at the Faculty of Medicine Siriraj Hospital: transapical vs. Transfemoral Approach. J Med Assoc Thai. 2021;104(5):846–852.
   Google Scholar
• Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370(19):1790–1798. doi:10.1056/NEJMoa1400590
   PubMed Web of Science ®Google Scholar
• Office of the Permanent Secretary, Ministry of Public Health. Public health statistics A.D. 2019; 2019. Available from: https://bps.moph.go.th/new_bps/sites/default/files/statistic62.pdf. Accessed June 30, 2022.
   Google Scholar
• Strange G, Stewart S, Celermajer D, et al. Poor long-term survival in patients with moderate aortic stenosis. J Am Coll Cardiol. 2019;74(15):1851–1863. doi:10.1016/j.jacc.2019.08.004
   PubMed Web of Science ®Google Scholar
• Riewpaiboon A. Measurement of costs for health economic evaluation. J Med Assoc Thai. 2014;97(Suppl 5):S17–26.
   PubMedGoogle Scholar
• Bureau of Trade and Economics Indices, Ministry of Commerce. Consumer price index; 2021. Available from: http://www.price.moc.go.th/price/cpi/index_new_all.asp. Accessed June 30, 2022.
   Google Scholar
• Bank of Thailand. Foreign exchange rate; 2021. Available from: www.bot.or.th/english/statistics/financialmarkets/exchangerate/_layouts/application/exchangerate/exchangerate.aspx. Accessed June 30, 2022.
   Google Scholar
• Pattanaphesaj J. Health-Related Quality of Life Measure (EQ-5D-5L): Measurement Property Testing and Its Preference-Based Score in Thai Population [Doctoral dissertation]. Bangkok: Mahidol University; 2014.
   Google Scholar
• Permsuwan U, Guntawongwan K, Buddhawongsa P. Handling time in economic evaluation studies. J Med Assoc Thai. 2014;97(Suppl 5):S50–S58.
   PubMedGoogle Scholar
• Thavorncharoensap M, Teerawattananon Y, Natanant S, Kulpeng W, Yothasamut J, Werayingyong P. Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter? Clinicoecon Outcomes Res. 2013;5:29–36. doi:10.2147/CEOR.S38062
   PubMedGoogle Scholar
• Briggs AH. Handling uncertainty in cost-effectiveness models. PharmacoEconomics. 2000;17(5):479–500. doi:10.2165/00019053-200017050-00006
   PubMed Web of Science ®Google Scholar
• Gada H, Kapadia SR, Tuzcu EM, Svensson LG, Marwick TH. Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients. Am J Cardiol. 2012;109(9):1326–1333. doi:10.1016/j.amjcard.2011.12.030
   PubMed Web of Science ®Google Scholar
• Fairbairn TA, Meads DM, Hulme C, et al. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk. Heart. 2013;99(13):914–920. doi:10.1136/heartjnl-2013-303722
   PubMed Web of Science ®Google Scholar
• Health Quality Ontario. Transcatheter aortic valve implantation for treatment of aortic valve stenosis: a health technology assessment. Ont Health Technol Assess Ser. 2016;16(19):1–94.
   Google Scholar
• Tarride JE, Luong T, Goodall G, Burke N, Blackhouse G. A Canadian cost-effectiveness analysis of SAPIEN 3 transcatheter aortic valve implantation compared with surgery, in intermediate and high-risk severe aortic stenosis patients. Clinicoecon Outcomes Res. 2019;11:477–486. doi:10.2147/CEOR.S208107
   PubMed Web of Science ®Google Scholar
• Geisler BP, Huygens SA, Reardon MJ, et al. Cost-effectiveness and projected survival of self-expanding transcatheter versus surgical aortic valve replacement for high risk patients in a European setting: a Dutch analysis based on the CoreValve high risk trial. Struct Heart. 2017;1(5–6):267–274. doi:10.1080/24748706.2017.1381357
   Google Scholar
• Inoue S, Nakao K, Hanyu M, et al. Cost-effectiveness of transcatheter aortic valve implantation using a balloon-expandable valve in Japan: experience from the Japanese Pilot Health Technology Assessment. Value Health Reg Issues. 2020;21:82–90. doi:10.1016/j.vhri.2019.07.013
   PubMedGoogle Scholar
• Reynolds MR, Magnuson EA, Lei Y, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol. 2012;60(25):2683–2692. doi:10.1016/j.jacc.2012.09.018
   PubMed Web of Science ®Google Scholar
• Gada H, Agarwal S, Marwick TH. Perspective on the cost-effectiveness of transapical aortic valve implantation in high-risk patients: outcomes of a decision-analytic model. Ann Cardiothorac Surg. 2012;1(2):145–155. doi:10.3978/j.issn.2225-319X.2012.06.12
   PubMedGoogle Scholar
• Doble B, Blackhouse G, Goeree R, Xie F. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective. J Thorac Cardiovasc Surg. 2013;146(1):52–60.e53. doi:10.1016/j.jtcvs.2012.06.018
   PubMed Web of Science ®Google Scholar
• Reynolds MR, Lei Y, Wang K, et al. Cost-effectiveness of transcatheter aortic valve replacement with a self-expanding prosthesis versus surgical aortic valve replacement. J Am Coll Cardiol. 2016;67(1):29–38. doi:10.1016/j.jacc.2015.10.046
   PubMed Web of Science ®Google Scholar
• Neyt M, Van Brabandt H, Devriese S, Van De Sande S. A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ open. 2012;2(3):e001032. doi:10.1136/bmjopen-2012-001032
   PubMed Web of Science ®Google Scholar
• Orlando R, Pennant M, Rooney S, et al. Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation. Health Technol Assess. 2013;17(33):1–86. doi:10.3310/hta17330
   PubMed Web of Science ®Google Scholar